Drugs / Biodentine

Trials 17 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT03395496 May 2013 → May 2016 dental caries, dental pulp disorder Istanbul University Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT03838094 Feb 2016 → Aug 2018 exposure, dental pulp Gihan M Abuelniel ,PhD Completed No outcome recorded
Phase 2/32 trials
Phase 2/3 NCT03838068 Jan 2017 → Dec 2018 exposure, dental pulp Gihan M Abuelniel ,PhD Completed No outcome recorded
Phase 2/3 NCT02492841 Apr 2014 → Apr 2016 dental caries, exposure, dental pulp Universidad de los Andes, Chile Completed No outcome recorded
Phase 33 trials
Phase 3 NCT02868918 Feb 2018 → Jan 2019 dental caries Cairo University Completed No outcome recorded
Phase 3 NCT03135626 Mar 2013 → Jan 2014 dental caries Istanbul University Completed No outcome recorded
Phase 3 NCT01733420 Oct 2011 → Nov 2015 dental caries University Ghent Completed No outcome recorded
Phase 43 trials
Phase 4 NCT06683833 Sep 2025 → May 2026 overdue dental caries Cairo University Recruiting No outcome recorded
Phase 4 NCT06695208 Dec 2024 → Dec 2025 overdue Cairo University Recruiting No outcome recorded
Phase 4 NCT03426046 Nov 2013 → Apr 2016 dental caries Didem Sakaryali Completed No outcome recorded
Phase not applicable7 trials
NCT05937100 May 2023 → Jul 2025 overdue exposure, dental pulp Mansoura University Active not recruiting No outcome recorded
NCT07120321 Jan 2022 → Jan 2025 dental caries, pulpitis Sacide Duman Completed No outcome recorded
NCT05006755 Sep 2021 Amany hasanean Abd El sadek Unknown No outcome recorded
NCT05296213 Dec 2019 → Dec 2021 enamel caries Mansoura University Completed No outcome recorded
NCT03589560 Jan 2015 → Aug 2017 dental pulp necrosis Cairo University Completed No outcome recorded
NCT02803528 Jan 2015 → Jan 2017 dental caries Damascus University Completed No outcome recorded
NCT02805101 Jan 2015 → Jun 2017 isolated congenital femoral bifurcation Damascus University Completed No outcome recorded
Also used as a comparator or background therapy in 9 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT05479877 Comparator Sep 2022 → Sep 2023 exposure, dental pulp Cairo University Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT03786302 Comparator Dec 2016 → Aug 2018 dental pulp disorder Nourhan M.Aly Terminated No outcome recorded
Phase 44 trials
Phase 4 NCT06435065 Comparator Apr → Jun 2024 pulpitis DR SURINDER SACHDEVA Unknown No outcome recorded
Phase 4 NCT06020911 Comparator Jan → Oct 2023 pulp degeneration Tanta University Completed No outcome recorded
Phase 4 NCT04773886 Comparator Feb 2020 → Mar 2021 pulpitis Maharishi Markendeswar University (Deemed to be University) Completed No outcome recorded
Phase 4 NCT04198298 Comparator Nov 2014 → May 2017 suppurative periapical periodontitis University of the Pacific Completed No outcome recorded
Phase not applicable3 trials
NCT06880471 Comparator Dec 2024 → Oct 2025 pulpitis Cumhuriyet University Completed No outcome recorded
NCT07066410 Comparator Oct 2023 → Oct 2025 overdue pulpitis British University In Egypt Active not recruiting No outcome recorded
NCT05582317 Comparator May 2021 → May 2022 pulpitis Suez Canal University Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 27 sources stand behind the page.

FieldValueCited text
Known as Biodentine “The aim of this randomized controlled trial is to compare partial pulpotomy treatments with Biodentine®, calcium hydroxide (CH) and Mineral Trioxide Aggregate (MTA) in...” NCT03426046
28

Biodentine™ has frequently been acknowledged in the literature as a promising material and serves as an important representative of tricalcium silicate based cements used in dentistry.” PMID 29372451 Jan 2018

“The Clinical and Radiographic Efficacy of Biodentine™ and White Mineral Trioxide Aggregate in Deciduous Molar Pulpotomy - a Randomized Control Trial” NCT01733420

“Partial pulpotomy treatment with BiodentineNCT03426046

Biodentine®” NCT04198298

NCT05479877

NCT06695208

NCT06435065

NCT05937100

NCT02492841

NCT01733420

NCT05006755

NCT04773886

NCT02803528

NCT07066410

NCT04198298

NCT03786302

NCT02868918

NCT03395496

NCT03838068

NCT06683833

NCT06880471

NCT06020911

NCT02805101

NCT03135626

NCT03589560

NCT03838094

NCT05582317

NCT07120321

Known as tricalcium silicate ClinicalTrials.gov intervention name — accepted as the source's own label NCT05296213
Modality Other / unclassified “Is a calcium-silicate based materia root perforations, apexification, resorptive lesions, and retrograde filling material in endodontic surgery, pulp capping” NCT02492841
Route Other “The mixture of Biodentine is introduced into the pulp chamber” NCT05582317